Levothroid

Levothroid is a brand name of levothyroxine, approved by the FDA in the following formulation(s):

LEVOTHROID (levothyroxine sodium - tablet; oral)

• 
  Manufacturer: LLOYD
  
  Approval date: October 24, 2002
  
  Strength(s): 0.025MG ^[AB4], 0.05MG ^[AB4], 0.075MG ^[AB4], 0.088MG ^[AB4], 0.112MG ^[AB4], 0.125MG ^[AB4], 0.15MG ^[AB4], 0.175MG ^[AB4], 0.1MG ^[AB4], 0.2MG ^[AB4], 0.3MG ^[RLD][AB4]


• 
  Manufacturer: LLOYD
  
  Approval date: December 7, 2004
  
  Strength(s): 0.137MG ^[AB4]

Has a generic version of Levothroid been approved?

No. There is currently no therapeutically equivalent version of Levothroid available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Levothroid. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Levothroid.

See also...

• Levothroid Consumer Information (Cerner Multum)
• Levothroid Advanced Consumer Information (Micromedex)
• Levothyroxine Consumer Information (Drugs.com)
• Levothyroxine Consumer Information (Wolters Kluwer)
• Levothyroxine Capsules Consumer Information (Wolters Kluwer)
• Levothyroxine Solution Consumer Information (Wolters Kluwer)
• Levothyroxine Consumer Information (Cerner Multum)
• Levothyroxine Advanced Consumer Information (Micromedex)
• Levothyroxine Injection Advanced Consumer Information (Micromedex)
• Levothyroxine Sodium AHFS DI Monographs (ASHP)